Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 56

Results For "ADA"

822 News Found

Challenges of Thalassemia management in India bring like-minded stakeholders together
Public Health | May 08, 2022

Challenges of Thalassemia management in India bring like-minded stakeholders together

Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India


Quality issues force Novartis to suspend production of radioligand therapy medicines
News | May 08, 2022

Quality issues force Novartis to suspend production of radioligand therapy medicines

The production suspension impacts commercial and clinical trial supply


Gut microbiome as a tool in regenerative medicine
Biotech | May 07, 2022

Gut microbiome as a tool in regenerative medicine

Novel approach driven by GN Corp Japan with potentials in neurological illnesses


Fujifilm India installs Endobronchial Ultrasound System (EBUS) at ESIC Hospital, Faridabad
Hospitals | May 06, 2022

Fujifilm India installs Endobronchial Ultrasound System (EBUS) at ESIC Hospital, Faridabad

The EBUS is designed to support the diagnosis and staging of various lung disorders


Sawai Man Singh Medical College (SMS), Jaipur collaborates with Intuitive India
Healthcare | May 05, 2022

Sawai Man Singh Medical College (SMS), Jaipur collaborates with Intuitive India

The workshop was organized by the Department of Urology as a first step to enabling government medical colleges in Rajasthan to offer the latest surgical technology


Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India
Biotech | May 04, 2022

Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India

Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication


CIVCO Radiotherapy to Unveil TotalRT All in One Solution at ESTRO 2022
Biotech | May 02, 2022

CIVCO Radiotherapy to Unveil TotalRT All in One Solution at ESTRO 2022

CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes


USFDA approves Rinvoq as an oral treatment for ankylosing spondylitis
Drug Approval | May 01, 2022

USFDA approves Rinvoq as an oral treatment for ankylosing spondylitis

The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases


AstraZeneca expands its ‘Young Health Program’ in Delhi
Public Health | April 29, 2022

AstraZeneca expands its ‘Young Health Program’ in Delhi

For over a decade, AstraZeneca and Plan India’s Young Health Program have been generating awareness and identifying sustainable solutions to influence the behaviour of youths against Non-Communicable Diseases


Biocytogen signs RenMab/RenLite licensing agreement with BeiGene
Biotech | April 26, 2022

Biocytogen signs RenMab/RenLite licensing agreement with BeiGene

In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)